Evidence map›Paper›PMID 36960396›Full record

ArticleFrontiers in endocrinology2023

Different cell compositions and a novel somatic

Liling Zhao, Jinjing Wan, Yujun Wang, Wenjun Yang, Qi Liang, Jinrong Wang, Ping Jin

Open access · goldFull text readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Case Report: SomaticFrontiers in medicine · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liling ZhaoDepartment of Endocrinology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jinjing WanDepartment of Endocrinology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yujun WangDepartment of Endocrinology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wenjun YangDepartment of Endocrinology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Qi LiangDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jinrong WangDepartment of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ping JinDepartment of Endocrinology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Third Xiangya Hospital · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to explore the possible pathogenesis of a rare case of co-existing Cushing's syndrome (CS) and primary aldosteronism (PA) caused by bilateral adrenocortical adenomas secreting aldosterone and cortisol, respectively. Methods: A 41-year-old Chinese woman with severe hypertension and hypokalemia for 5 and 2 years, respectively, was referred to our hospital. She had a Cushingoid appearance. Preoperative endocrinological examinations revealed autonomous cortisol and aldosterone secretion. Computed tomography revealed bilateral adrenal adenomas. Subsequently, adrenal vein sampling and sequential left and right partial adrenalectomy indicated the presence of a left aldosterone-producing tumor and a right cortisol-producing tumor. Pathological examination included immunohistochemical analysis of the resected specimens. Secretions of aldosterone and cortisol were observed both Results: Immunohistochemical staining revealed that the left adenoma primarily comprised clear cells expressing CYP11B2, whereas the right adenoma comprised both eosinophilic compact and clear cells expressing CYP11B1. The mRNA levels of steroidogenic enzymes (including CYP11B1 and CYP17A1) were high in the right adenoma, whereas CYP11B2 was highly expressed in the left adenoma. A novel somatic heterozygous missense variant- Conclusion: We present an extremely rare case of bilateral adrenocortical adenomas with distinct secretion of aldosterone and cortisol. The heterogeneity of the tumor cell compositions of aldosterone- and cortisol-producing adenoma (A/CPA) and somatic mutation of

Indexed as

AdenomaAdrenal Cortex NeoplasmsAdrenocortical AdenomaCushing SyndromeHyperaldosteronismAdultAldosteroneCytochrome P-450 CYP11B2FemaleG Protein-Coupled Inwardly-Rectifying Potassium ChannelsHumansHydrocortisoneSteroid 11-beta-HydroxylaseAldosteroneCytochrome P-450 CYP11B2G Protein-Coupled Inwardly-Rectifying Potassium ChannelsHydrocortisoneKCNJ5 protein, humanSteroid 11-beta-Hydroxylaseadrenal vein samplingaldosterone- and cortisol-producing adenomaCushing’s syndromeCYP11B1CYP11B2KCNJ5 geneprimary aldosteronism

Identifiers

PMID36960396
PMCPMC10028271
OpenAlexW4323363463

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read53
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.